Expect U.S. CBD market to be $13B by 2023 (page 8)
CBD Beverages in U.S. expected to have, by far, the greatest rate of growth (CAGR) of all CBD categories btwn 2020-2025, outpacing the 2nd place category by 50% (page 12)
Plans on launching CBD Isolate Beverages (RTD) in US in Fall 2020 (page 26)
Because of how closely Canopy has worked with the FDA, I don’t believe they would launch CBD Beverages until the FDA issues their Enforcement Discretion Regulations for CBD
Therefore, Canopy believes CBD Isolate Beverages will be permitted by the FDA via its CBD Enforcement Discretion Policy by Q4 2020
— — —
Today’s Canopy presentation is nothing new — they had the same timeline for CBD Isolate Beverages a few months ago
What’s important is that their timeline has not shifted since then
Breadcrumb #12 has the details on Canopy’s prior statements from June 2020:
It is very slim pickings in the CBD Beverage sector KGKG and BLEG are clearly the top 2 stocks in this very explosive (when FDA issues Enforcement Discretion for CBD) subsector
Float size, uniqueness of beverages (both monopoly stocks) and rate of dilution are the most important factors in terms of predicting % gain moving forward
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.